Sarcopenia, Muscle Mass and Protein Intake in Adults Older Than 65 Years After Earlier Bariatric Surgery
Journal of Cachexia, Sarcopenia and Muscle · 2025
DOI: 10.1002/jcsm.13839 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Gabriël Eksteen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Bariatric Surgery, Dietary Proteins, Muscle, Skeletal, Sarcopenia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 research and innovation program: Marie Skłodowska-Curie.
Abstract (Originalsprache)
Background
Metabolic and bariatric surgery (MBS) is a proven treatment for obesity. Yet weight loss is accompanied by loss of muscle which may predispose to sarcopenia. The prevalence of low muscle mass in older adults after MBS remains unexplored, even though this group is more vulnerable to sarcopenia.
Methods
This cross‐sectional study investigated sarcopenia and low muscle mass by comparing adults older than 65 years with previous MBS (BAR) to patients following nonsurgical obesity management (CON). A sample size of 100 was estimated from appendicular lean mass (ALM) in a similar study in younger adults. Patients were recruited from the University Hospitals Leuven Obesity Clinic, Belgium. Study assessments included dual‐energy X‐ray absorptiometry, handgrip, short battery of physical performance, blood sampling and self‐reported dietary intake. Sarcopenia was defined according to the European Working Group on Sarcopenia in Older People (EWGSOP1) criteria using obesity‐specific cut‐off points and sarcopenic obesity by the European Society for Enteral and Parenteral Nutrition (ESPEN) and the European Association of the Study of Obesity (EASO) consensus definition. Main endpoints were sarcopenia and ALM normalized to body mass index (%ALM/BMI). A multiple linear regression model was fitted to predict ALM.
Results
We included 50 participants per group (male, BAR 40%, CON 35%). BAR participants were older (68.3 ± 3.2 years vs. 70.7 ± 3.9, p < 0.01), and more had diabetes (52% vs. 28%). BAR lost more bodyweight after MBS than CON following nonsurgical treatment (BAR 31.6 ± 9.5% vs. CON 12.1 ± 8.42%, p < 0.001). Fat free mass (FFM) was lower for BAR than for CON, but %ALM/BMI was not different (64.7 ± 18.1% vs. 62.6 ± 15.8, p = 0.53). Twenty percent to 56% of participants had low muscle mass, depending on sex and criterium, but only 3% met the criteria for sarcopenia and 9% for sarcopenic obesity. Protein intake tended to be higher in BAR than in CON (1.36 ± 0.36 g/kg FFM/day vs. 1.25 ± 0.27, p = 0.09). Most participants did not meet optimal protein intake recommendations after BMS nor for older adults in general. In the linear regression model, muscle mass increased with male sex, BMI, adiposity and protein intake and decreased with age, (adjusted R 2 0.80). Neither BAR compared to CON nor surgery type or other clinical parameters influenced muscle mass.
Conclusion
Older adults with previous MBS were not more likely to develop sarcopenia than older adults following nonsurgical treatment. Rather, age, adiposity and low protein intake lower muscle mass, predisposing to sarcopenia. Trial Registration: clinicaltrials.gov identifier: NCT05582668.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.
- Translational Research in Gastrointestinal Disorders, KU Leuven, University Hospitals Leuven, Leuven, Belgium.
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
- Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium.
- Department of Abdominal Surgery, University Hospitals Leuven, Leuven, Belgium.
ORCID-Profile: Gabriël Eksteen, Tim Vanuytsel, Roman Vangoitsenhoven, Ann Mertens, Matthias Lannoo, Ellen De Leus, Bart Van der Schueren, Christophe Matthys
Förderung
- Horizon 2020 research and innovation program: Marie Skłodowska-Curie
Zitieren
APA
Eksteen, G., Vanuytsel, T., Vangoitsenhoven, R., Mertens, A., Lannoo, M., De Leus, E., Van der Schueren, B., & Matthys, C. (2025). Sarcopenia, Muscle Mass and Protein Intake in Adults Older Than 65 Years After Earlier Bariatric Surgery. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13839
Vancouver
Eksteen G, Vanuytsel T, Vangoitsenhoven R, Mertens A, Lannoo M, De Leus E, et al. Sarcopenia, Muscle Mass and Protein Intake in Adults Older Than 65 Years After Earlier Bariatric Surgery. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13839
BibTeX
@article{Eksteen2025,
author = {Eksteen, Gabriël and Vanuytsel, Tim and Vangoitsenhoven, Roman and Mertens, Ann and Lannoo, Matthias and De Leus, Ellen and Van der Schueren, Bart and Matthys, Christophe},
title = {Sarcopenia, Muscle Mass and Protein Intake in Adults Older Than 65 Years After Earlier Bariatric Surgery},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
doi = {10.1002/jcsm.13839}
}
EUVIMED